bluebird bio, Inc. (BLUE) earnings
BLUE earnings moved a median of -0.15% by the close. Quarterly and annual BLUE reports and results, each read against the price at its own news timestamp. Back to the BLUE overview →
22 measured BLUE earnings events.
Where these BLUE earnings landedvs 22 measured BLUE earnings reactions
| Middle 50% of BLUE earnings reactions | -6.03% to +2.27% |
|---|---|
| Median reaction (to close) | -0.15% |
| Measured reactions | 22 |
Point-in-time · zero look-ahead
Half of the 22 BLUE earnings events with a measured close landed between -6.03% and +2.27%; 41% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q bluebird bio, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -0.20% | |
| Form 10-K bluebird bio, Inc. For: Dec 31 | SEC filing · Form 10-K | -0.93% | +7.94% | |
| bluebird bio Reports Third Quarter 2024 Results and Highlights Operational Progress and 2024 Guidance | Press release | -0.32% | -2.26% | |
| Form 10-Q bluebird bio, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.32% | -2.26% | |
| bluebird bio Adjourns Meeting of Stockholders and Announces Third Quarter Results Call | Press release | -8.02% | -11.14% | |
| bluebird bio Announces Completion of its Q2 2024 Form 10-Q Filing | Press release | +1.90% | -0.10% | |
| Form 10-Q bluebird bio, Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.90% | -0.10% | |
| bluebird bio Announces Completion of its Restatement and filing of its 2023 Form 10-K and Q1 2024 Form 10-Q | Press release | -3.05% | -6.85% | |
| Form 10-K bluebird bio, Inc. For: Dec 31 | SEC filing · Form 10-K | -3.05% | -6.85% | |
| Form 10-Q bluebird bio, Inc. For: Mar 31 | SEC filing · Form 10-Q | -3.05% | -6.85% | |
| bluebird bio Reports Second Quarter 2024 Results and Highlights Operational Progress and 2024 Guidance | Press release | -1.81% | -14.22% | |
| Form NT 10-Q bluebird bio, Inc. For: Jun 30 | SEC filing · Form NT | -1.81% | -14.22% | |
| bluebird bio Announces Second Quarter 2024 Results Call Date | Press release | -2.14% | -3.58% | |
| Form NT 10-Q bluebird bio, Inc. For: Mar 31 | SEC filing · Form NT | -2.80% | -1.87% | |
| bluebird bio Reports First Quarter 2024 Results and Highlights Operational Progress and 2024 Guidance | Press release | +0.99% | +9.80% | |
| bluebird bio Announces First Quarter 2024 Results Call Date and Upcoming Investor Events | Press release | -1.25% | +7.69% | |
| bluebird bio Reports Fourth Quarter and 2023 Annual Results and Highlights Operational Progress and 2024 Guidance | Press release | -3.82% | +0.84% | |
| Form NT 10-K bluebird bio, Inc. For: Dec 31 | SEC filing · Form NT | -3.82% | +0.84% | |
| bluebird bio to Host Fourth Quarter and 2023 Annual Results Conference Call | Press release | -3.82% | +0.84% | |
| bluebird bio Reports Third Quarter 2023 Financial Results and Highlights Operational Progress | Press release | -2.62% | +2.91% | |
| Form 10-Q bluebird bio, Inc. For: Sep 30 | SEC filing · Form 10-Q | -2.62% | +2.91% | |
| bluebird bio to Host Third Quarter 2023 Financial Results Conference Call | Press release | +3.25% | +2.74% |
Keep exploring
More BLUE: analyst actions → · SEC filings → · BLUE overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Cerecor, Inc (CERC) | 795 | -0.03% | 43% |
| Second Sight Medical Products, Inc. (EYES) | 788 | -0.56% | 34% |
| Actinium Pharmaceuticals, Inc. (Delaware) (ATNM) | 784 | 0.00% | 45% |
| Heat Biologics, Inc. (HTBX) | 781 | -0.40% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.